Table 2 Sensitivities of the various assays based on the analysis of 999 confirmed syphilis cases according to clinical stage.
From: Evaluation of the Elecsys syphilis immunoassay for routine screening of serum samples in China
Stage | Elecsys vs. Architect | Elecsys vs. InTec ELISA | Elecsys vs. KHB ELISA | ||||||
|---|---|---|---|---|---|---|---|---|---|
N | Elecsys | Architect | N | Elecsys | InTec ELISA | N | Elecsys | KHB ELISA | |
I (primary) | 20 | 100% | 100% | 44 | 100% | 100% | 2 | 100% | 100% |
II (secondary) | 55 | 100% | 100% | 74 | 100% | 100% | 24 | 100% | 100% |
III (tertiary) | 6 | 100% | 100% | 24 | 100% | 100% | 6 | 100% | 100% |
Latent | 96 | 100% | 100% | 149 | 100% | 100% | 56 | 100% | 100% |
Unclassified | 178 | 100% | 100% | 100 | 100% | 100% | 165 | 100% | 100% |
Total | 355 | 100% | 100% | 391 | 100% | 100% | 253 | 100% | 100% |
